D - 122
Asia-Pacific CardioMetabolic Syndrome Congress 2025
Copenhagen University Hospital, University of Copenhagen, Denmark
"Residual lipid risk in ASCVD"
Brigham and Women’s Hospital, Harvard Medical School
"Omics Applications for the Prevention of Cardiometabolic Disease"
Sapienza University of Rome, Italy
"Neuroimmune regulation of cardiovascular disease"
Karolinska Institute, Sweden
"Treatment of obesity and type 2 diabetes-now and in the near future"
Korea
"Lipotoxicity and Metabolic Disease: A Protective Role of SENP2"
Fukuoka University, Japan
"Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome"
Lund University, Sweden
"Gaps and opportunities for the clinical translation of precision medicine in cardiometabolic diseases"
Juntendo University, Japan
"Cholesterol Efflux Capacity: Clinical Significance and Unresolved Issues"
Moriyama Memorial Hospital, Japan
"Pharmacological Approaches to Cardiometabolic Syndrome: From Small Molecules to siRNA Therapeutics?"
University of California, San Diego, USA
"Building Cardiometabolic Resilience: From Metabolic Syndrome to Long COVID"
K-Heart Clinic and Lab, Korea
"You should know how to use statins wisely; otherwise, there could be legal consequences"
Jichi Medical University, Japan
"Uric Acid, Hypertension, and Cardiovascular Disease"
Kyushu University, Japan
"Kidney-brain-heart connection in hypertension and hypertensive heart failure"
